Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Expected characteristics of an ideal, all-purpose inhaled corticosteroid for the treatment of asthma
2003
A comparison of the efficacy and safety of inhaled corticosteroids in asthma
1997
Visible light photoredox catalysis: applications in organic synthesis
2010 Standout
Atopic dermatitis
2003 Standout
Eosinophilic Inflammation in Asthma
1990 Standout
Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate
1996
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO ) for Clinical Applications
2011 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins
1995
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
2014 Standout
Variability of symptoms in mild persistent asthma: baseline data from the MIAMI study
2004
Melioidosis
2003 Standout
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
1998 Standout
Catalysis for fluorination and trifluoromethylation
2011 StandoutNature
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
KEY ISSUES IN ADVANCED BLEEDING CARE IN TRAUMA
2006
Fluorine in Medicinal Chemistry
2015
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
2000
Oral Corticosteroid Therapy for Patients with Stable Chronic Obstructive Pulmonary Disease
1991
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Asthma
2017 Standout
Withdrawal From Treatment as an Outcome in the ISOLDE Study of COPD
2003
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—A randomised study
1993
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
2014
Systemic Adverse Effects of Inhaled Corticosteroid Therapy
1999
Effects of Long-term Treatment With Corticosteroids in COPD
1996
Ceftazidime pharmacokinetics in preterm infants: Effects of renal function and gestational age*
1995
Pharmacokinetic‐pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis
2000
Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence
2003
Post-antibiotic and post- -lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum -lactamase-producing Gram-negative bacteria
2004
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Fluticasone at different doses for chronic asthma in adults and children
2005
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Pharmacokinetics and systemic activity of fluticasone via Diskus® and pMDI, and of budesonide via Turbuhaler®
2001
SF-36 Health Survey Update
2000 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
tBuLi‐Mediated One‐Pot Direct Highly Selective Cross‐Coupling of Two Distinct Aryl Bromides
2015 StandoutNobel
Controlled trial of oral prednisone in outpatients with acute COPD exacerbation.
1996
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy
1991
Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines
2005
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Randomized Controlled Trial to Improve Care for Urban Children With Asthma
2011
Fluticasone Propionate Improves Quality of Life in Patients with Asthma Requiring Oral Corticosteroids
1996
Pulmonary hypertension secondary to neurofibromatosis: intimal fibrosis versus thromboembolism
1999
Comparative Efficacy and Safety of Low-dose Fluticasone Propionate and Montelukast in Children with Persistent Asthma
2005
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Role of Antimicrobial Pharmacokinetics and Pharmacodynamics in Surgical Prophylaxis
1991
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Do Inhaled Corticosteroids Inhibit Growth in Children?
2001
Safety and Efficacy of Fluticasone and Beclomethasone in Moderate to Severe Asthma
1998
Can Guideline-defined Asthma Control Be Achieved?
2004
Withdrawal of Chronic Systemic Corticosteroids in Patients with COPD
2000
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
1987 Standout
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Fluorine in medicinal chemistry
2007 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children
2004
Steroid Response in Stable Chronic Obstructive Pulmonary Disease
1982
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC Study
2005
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate
1999
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
1999
Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years
2001
β-Lactam Antibiotics: Structural Relationships Affecting in Vitro Activity and Pharmacologic Properties
1986
Interventions for enhancing medication adherence
2014 Standout
Structural and Biochemical Studies of a Fluoroacetyl-CoA-Specific Thioesterase Reveal a Molecular Basis for Fluorine Selectivity
2010 StandoutNobel
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
The Crisis in Antibiotic Resistance
1992 StandoutScience
Fluticasone at different doses for chronic asthma in adults and children
2008
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast
2000
European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design
1992
Aromatic Trifluoromethylation with Metal Complexes
2011 Standout
Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma
1983
Visible Light Photoredox Catalysis with Transition Metal Complexes: Applications in Organic Synthesis
2013 Standout
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma
2002
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of Stuart M. Harding being referenced
Long-term Efficacy and Safety of Fluticasone Propionate Powder Administered Once or Twice Daily via Inhaler to Patients With Moderate Asthma
2000
Pharmacokinetics of Fluticasone Propionate Inhaled via the Diskhaler?? and Diskus?? Powder Devices in Patients with Mild-to-Moderate Asthma
2000
Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma
1999
Fluticasone propionate powder: Oral corticosteroid–sparing effect and improved lung function and quality of life in patients with severe chronic asthma
1999
Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by Diskus device in patients with asthma treated with or without inhaled corticosteroids
2000
Potential Effects of Fluticasone Propionate on Bone Mineral Density in Patients With Asthma: A 2-Year Randomized, Double-Blind, Placebo-Controlled Trial
2004
Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma
1999
The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers
1981
Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma
2000
A Dose-Ranging Study of Fluticasone Propionate Administered Once Daily via Multidose Powder Inhaler to Patients With Moderate Asthma
2000
A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response.
1978
The clinical pharmacology of ondansetron.
1989
The pharmacokinetic behaviour of ceftazidime in man and the relationship between serum levels and the in vitro susceptibility of clinical isolates
1983
GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity
1980
The human pharmacology of fluticasone propionate
1990
Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid
1982
Pharmacokinetics of ceftazidime in male and female volunteers
1983
Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction.
1994
Pharmacokinetics of ceftazidime in normal subjects
1981